How Long Does Tirzepatide Last in the Fridge? Storage Timeline by Form

Sealed lyophilized tirzepatide stored at standard refrigerator temperature retains greater than 95% potency for 18 to 24 months. The exact duration depends on the manufacturer's stability data and the excipients used in the formulation. Most compounding pharmacies assign a beyond-use date (BUD) of 6 months because USP <797> requires product-specific stability data to claim longer, and many pharmacies have not conducted those tests.

The practical implication: a compounded vial labeled with a 6-month BUD may retain potency longer than 6 months. But without stability data to confirm that, the labeled date is the only reliable guideline. Respect it.

Store the vial in the back of the refrigerator, never in the door. Door shelves experience temperature swings of 5-8°C with each opening. A vial stored in the door for three months accumulates more thermal stress than one stored on a back shelf for six months. For comprehensive storage principles, see the peptide storage guide.

Eli Lilly's pre-filled pens contain tirzepatide in a proprietary liquid formulation engineered for stability. Unopened pens stored at 2-8°C remain potent until the printed expiration date, typically 18 to 24 months from production. The buffer system, excipients, and controlled manufacturing environment give these pens a longer verified shelf life than most compounded preparations.

Once you remove a pen from the refrigerator or use it for the first time, Eli Lilly specifies a 21-day window at room temperature (up to 30°C / 86°F). After 21 days at room temperature, discard the pen. Do not return it to the fridge and assume the clock resets. It does not. The 21-day limit accounts for cumulative degradation at higher temperatures.

Never freeze a pre-filled pen. The freeze-thaw cycle damages the protein structure and can alter the pen's delivery mechanism. If a pen has been frozen, discard it.

If you plan to store lyophilized tirzepatide for longer than six months before use, a standard kitchen freezer at -20°C extends shelf life to 24-36 months. At this temperature, degradation reactions slow to the point where potency loss is negligible over two years.

Freezer storage is appropriate only for lyophilized (powder) tirzepatide. Never freeze reconstituted tirzepatide. Ice crystals physically shear peptide bonds and cause irreversible aggregation, destroying 30-50% of the active molecule in a single freeze-thaw cycle. This distinction matters: powder in the freezer is fine; liquid in the freezer is destroyed.

Wrap vials in aluminum foil or store them in the original packaging to block light. Even in a dark freezer, brief light exposure during door openings compounds over months.

The 28-day limit is not arbitrary. It reflects the point at which the peptide is expected to retain at least 90% of its labeled potency under refrigeration, the minimum threshold the pharmaceutical industry considers acceptable. Below 90%, dose-response relationships become unreliable.

At 2-8°C, deamidation proceeds slowly enough to keep potency above that line for four weeks. At room temperature (25°C), the same 10% loss occurs in roughly 7 to 10 days. The Arrhenius equation predicts that reaction rates approximately double for every 10°C increase in temperature. This is why refrigeration buys four times the shelf life of a countertop.

The SURMOUNT-1 trial demonstrated that each tirzepatide dose tier (5 mg, 10 mg, 15 mg) produced measurably different weight loss outcomes (Jastreboff et al., NEJM, 2022). A 10-15% potency loss effectively drops your dose to a lower tier without your knowledge. For dosing details, see how many units is 2.5 mg of tirzepatide.

Reconstituted tirzepatide does not degrade linearly. Potency drops gradually at first, then accelerates as degradation products catalyze further breakdown.

By day 28 at 2-8°C, potency remains within the pharmaceutical standard. By day 42, it has dropped below 90% for many vials. By day 28 at room temperature, more than a third of the active peptide may be gone. This is why reconstituted vials belong in the fridge at all times except the 30-60 seconds you need to draw a dose.

For broader context on reconstituted peptide timelines, see how long do reconstituted peptides last.

The solvent you choose determines whether your vial lasts 28 days or 48 hours. Bacteriostatic water contains 0.9% benzyl alcohol, a preservative that suppresses bacterial growth. Sterile water for injection contains no preservative.

Use bacteriostatic water for any vial you plan to draw from more than once. Use sterile water only if you intend to draw the entire contents in a single session and discard the vial immediately.

Each needle puncture through the rubber stopper introduces a contamination pathway. After 15 to 20 punctures, the stopper may no longer seal properly. Keep puncture counts low by drawing accurate volumes each time. Use the tirzepatide dosage calculator to determine the exact volume before you uncap a needle. For mixing ratios, see how much bacteriostatic water for semaglutide (the principles apply across all GLP-1 agonists).

Eli Lilly conducts 12 to 24 months of accelerated stability testing under International Council for Harmonisation (ICH) Q1A guidelines before assigning expiration dates. The pens benefit from a proprietary buffer system, precise pH control, and excipients selected for long-term stability (ICH Q1A(R2), 2003).

The result: unopened pens last until the printed date (18-24 months from manufacture) in the fridge. After first use or removal from refrigeration, 21 days at room temperature. This window is clinically validated through stability testing. Pens should not be stored above 30°C or exposed to direct sunlight.

If you travel frequently, the 21-day room-temperature tolerance makes pens more practical than reconstituted vials. A two-week vacation does not require a cold pack if the pen stays below 30°C.

Compounding pharmacies operate under USP <797> and USP <795> standards, which are less rigorous than ICH guidelines. Many pharmacies assign a beyond-use date of 6 months for lyophilized preparations and 28 to 45 days for reconstituted solutions. These dates are conservative estimates, not the result of product-specific stability studies.

A compounded vial labeled with a 6-month BUD stored at 2-8°C may retain potency for 12 months or more. But without testing data, that remains speculation. The quality of excipients, the purity of the starting material, and the sterility of the compounding environment all introduce variables that Eli Lilly's manufacturing process controls more tightly.

The cost calculation matters here. A compounded vial that expires before you finish it wastes both product and money. Plan your tirzepatide dosing schedule against the labeled BUD. If the math does not work, order smaller vials or split orders with your prescriber's guidance.

A reconstituted vial left at room temperature (20-25°C) overnight loses approximately 1-3% potency. That loss is measurable in a laboratory but unlikely to produce a noticeable change in clinical effect. Return the vial to the fridge and continue using it, but note the lapse. Multiple overnight lapses compound.

A sealed lyophilized vial left out overnight experiences negligible degradation. Powder tolerates room temperature for months. A single night is inconsequential.

A Mounjaro pen left out overnight begins its 21-day room-temperature clock if it was previously refrigerated. Eli Lilly's guidance does not distinguish between "accidentally left out for 8 hours" and "intentionally stored at room temperature." Once the pen warms, the countdown starts.

At this point, a reconstituted vial has lost 3-7% potency at 20-25°C. If the room was warmer (near 30°C in summer), losses can reach 8-10%. The vial is still usable if it passes visual inspection (clear, colorless, no particles), but you have effectively shortened its 28-day window by several days.

Pre-filled pens are within their 21-day tolerance. No action needed beyond noting the start of the countdown. Lyophilized powder remains unaffected.

A reconstituted vial left at room temperature for 5 or more days has likely lost 10-20% potency. By day 7 at 25°C, potency drops to 90-95%, approaching the pharmaceutical threshold. If the room was warm and the vial was exposed to light, discard it.

A reconstituted vial left in a hot car (40°C+) for even a few hours should be discarded. At 40°C, degradation accelerates roughly 8-fold compared to 2-8°C. A GLP-1 receptor agonist stability study found that oxidation of a single methionine residue at elevated temperatures reduced receptor binding affinity by 40-60% (Houen & Jakobsen, J Pharm Sci, 2019).

For signs that your vial has crossed the line, see our guide on whether tirzepatide expires.

Cloudiness. Fresh tirzepatide solution is clear and colorless. Any haziness or opalescence indicates protein aggregation. Aggregated peptides are less potent and potentially immunogenic. The immune system can recognize peptide aggregates as foreign and mount an antibody response. Discard cloudy solutions.

Particles. Hold the vial against a light source and rotate it slowly. Floating specks, flakes, or fibers mean contamination or advanced aggregation. A single small fiber may be a stopper fragment. Multiple particles mean the vial is done.

Color shift. The solution should be colorless to very faintly yellow. Any amber, brown, or unusual tint indicates oxidation. Discard immediately.

Gel or film. In advanced degradation, peptide aggregates form a gel-like coating on the vial walls or a film at the solution surface. This represents extensive structural damage beyond recovery.

The most telling sign of degraded tirzepatide is reduced efficacy. If your appetite suppression, weight loss, or glucose control has diminished on a previously stable dose without any change in diet, exercise, or medication, suspect the vial.

A 15-20% potency loss turns a 10 mg dose into an effective 8 to 8.5 mg dose. The SURMOUNT trials showed meaningful differences between dose tiers. Dropping from your intended dose to a lower one because of degradation will show in your results within 1-2 weeks.

Increased injection site discomfort can also signal degradation. Breakdown products lower the solution's pH, increasing tissue irritation. If a previously comfortable injection starts burning or stinging, that vial warrants scrutiny.

For a full breakdown of efficacy concerns, see does tirzepatide burn fat. If you experience side effects, consult does tirzepatide cause headaches.

Mounjaro and Zepbound pens tolerate 21 days at room temperature, making them the most travel-friendly option. For trips under three weeks in moderate climates, no cold storage is required. Keep the pen in your carry-on bag, away from direct sunlight, and below 30°C.

For trips in hot climates or exceeding 21 days, pack the pen in an insulated pouch with a cold gel pack. Avoid direct contact between the ice pack and the pen. A sock or small towel between them prevents accidental freezing. Frio wallets (evaporative cooling pouches) maintain 18-26°C for 24-48 hours without ice and are widely used by insulin-dependent travelers.

For air travel, carry tirzepatide in your cabin bag. Checked luggage endures temperature extremes in cargo holds that can reach -30°C or 50°C depending on the aircraft and season. TSA permits injectable medications with proper documentation. A letter from your prescriber or a pharmacy label is sufficient.

Reconstituted vials require unbroken refrigeration. Pack them in a medical-grade insulated cooler bag with gel packs pre-chilled to 2-8°C. Do not use loose ice cubes; they melt into water that can soak labels and compromise stopper seals.

Most hotel rooms have minibars or small refrigerators. Request one at booking. If unavailable, ask the hotel concierge to store your medication in the kitchen refrigerator. Medical storage requests are routine in the hospitality industry.

For road trips, a powered cooler (thermoelectric or compressor) that plugs into your car's 12V outlet maintains a consistent 2-8°C indefinitely. Standard coolers with ice packs hold temperature for 12-18 hours depending on ambient heat.

For more on storage fundamentals, see how to store peptides. For reconstitution instructions that start the 28-day clock, see how to reconstitute tirzepatide.

Pharmaceutical stability testing builds in a margin of safety. A single brief temperature excursion (2-4 hours above 8°C) does not typically push the peptide below the 90% potency threshold. The concern is cumulative exposure.

A vial that spends 30 minutes at room temperature during each of 28 daily dose draws accumulates 14 hours of warm exposure over its life. That is equivalent to roughly one full day at room temperature, enough to shave 1-3% off total potency. Minimize handling time. Draw the dose, return the vial, close the door. Sixty seconds or less.

If your home refrigerator runs warmer than expected (above 8°C), every vial in it degrades faster than the labeled timeline assumes. A $5 refrigerator thermometer eliminates this risk. Consumer refrigerators frequently run 2-3°C warmer than their dial setting, especially older models. Use the reconstitution calculator to plan dose volumes that minimize the number of draws per vial.

Moving lyophilized tirzepatide from the refrigerator (2-8°C) to the freezer (-20°C) extends shelf life from 18-24 months to 24-36 months. The powder contains virtually no moisture, so ice crystal formation is not a concern. A study on peptide pharmaceutical stability found that lyophilized formulations stored at -20°C retained greater than 95% potency for three years under ideal conditions (Manning et al., Pharm Res, 2010).

Standard kitchen freezers maintain approximately -18°C to -20°C, which is adequate. Deep freezers at -40°C offer marginal additional benefit. The meaningful jump is from 2-8°C to -20°C, not from -20°C to -40°C.

Freezing reconstituted tirzepatide creates ice crystals that physically tear peptide bonds. The freeze-thaw cycle causes irreversible aggregation, destroying 30-50% of the active peptide in a single event. A vial that was accidentally frozen should be discarded even if the solution looks clear after thawing. Aggregation damage is not always visible immediately; it manifests as reduced receptor binding and diminished clinical effect.

This rule applies to all reconstituted peptides. For a broader overview of reconstituted peptide handling, see how long do reconstituted peptides last.

Mounjaro and Zepbound pens contain liquid tirzepatide. Freezing follows the same physics as reconstituted vials: ice crystals damage the peptide structure. Additionally, freezing can damage the pen's spring mechanism and needle assembly, making it mechanically unreliable.

If a pen was left in a checked bag that reached sub-zero temperatures in a cargo hold, or stored near the back of a freezer by accident, discard it. Do not attempt to use it even if the solution appears normal.